Fibroblast growth factor 21 predicts arteriovenous fistula functional patency loss and mortality in patients undergoing maintenance hemodialysis
CONCLUSIONS: Serum FGF21 levels were an independent risk factor and predictor for AVF functional patency loss and all-cause mortality in patients undergoing MHD.PMID:38197433 | PMC:PMC10783836 | DOI:10.1080/0886022X.2024.2302407
Source: Renal Failure - Category: Urology & Nephrology Authors: Xinhui Hu Hong Ding Qing Wei Ruoxin Chen Weiting Zhao Liqiong Jiang Jing Wang Haifei Liu Jingyuan Cao Hong Liu Bin Wang Source Type: research
More News: Cardiology | Cardiovascular | Dialysis | Heart | Hemodialysis | Renal Failure | Study | Urology & Nephrology